Savannah Hamilton

The bill, titled "To prohibit Federal agencies from taking adverse action against those supporting cannabis-related businesses and to amend the Securities Exchange Act of 1934," was introduced in the 119th Congress as H.R. 7987 on March 18, 2026. The bill aims to protect individuals offering business assistance to cannabis-related legitimate businesses from federal agency repercussions and proposes amendments to establish a safe harbor for national securities exchanges to list securities of such businesses.

This bill, designated as S. 4066 in the 119th Congress and introduced on March 11, 2026, aims to declare that the approved application for the drug mifepristone under the Federal Food, Drug, and Cosmetic Act for ending intrauterine pregnancies is considered withdrawn. Additionally, it seeks to create a Federal tort claim for harm caused to women by chemical abortion drugs along with other related purposes.